This document provides an overview of BRCA genes and hereditary breast cancer. It discusses how most breast cancer is sporadic but about 5-10% is hereditary, often caused by mutations in BRCA1 and BRCA2 genes. Carriers of these mutations have a significantly higher risk of developing breast and ovarian cancers. Genetic testing is available and can help determine risk. For those who test positive, increased screening and preventative surgeries like mastectomies and salpingo-oophorectomies can help reduce cancer risk. The document outlines referral guidelines for genetic testing and discusses the benefits, risks, and limitations of testing.
BRCA – Importance in Hereditary Breast & Ovarian CancerLifecare Centre
BRCA – Importance in Hereditary
Breast & Ovarian Cancer
DGF & WOW India
presentation was made by
Dr Sharda Jain
based on presentation made by
Dr Sunil Tadepalli
Presentation from Peter Hulick, MD, MMSc, to help nurses and nurse practitioners:
1) Understand the genetic consultation process
2) Examine genetic contribution to breast cancer
3) Identify suggestive family history patterns and risk estimation
4) Influence of genetic testing on management
Taken from a CNE-granting presentation given on 2/17/12 in Highland Park, IL, put together by the Chicago Center for Jewish Genetic Disorders and NorthShore University HealthSystem.
As more women are concerned with their hereditary breast & Gyneacological cancer risk, the threshold for genetic testing is falling .
Patients and family members should be supported & given information about chemoprevention, surveillance & risk-reducing surgery .
The true challenge lies in translation of this knowledge into clinical practice, such that a definitive improvement in longevity and quality of life for patients and their families is realized.
Surviving and Thriving with Gynecologic Cancer - 9.7.19Summit Health
Join Gynecologic Oncology and wellness experts for a special "brunch and learn," event for ovarian, cervical and other gynecologic cancer survivors and champions. Speaker-led sessions will cover innovation in treatment and complementary medicine to help manage menopause and other symptoms. Moderated by Darlene Gibbon, MD. FACOG, Medical Director of Gynecologic Oncology.
Other event materials can be found under the Patient Tools tab on this page: https://www.summitmedicalgroup.com/service/gynecological-oncology/
BRCA – Importance in Hereditary Breast & Ovarian CancerLifecare Centre
BRCA – Importance in Hereditary
Breast & Ovarian Cancer
DGF & WOW India
presentation was made by
Dr Sharda Jain
based on presentation made by
Dr Sunil Tadepalli
Presentation from Peter Hulick, MD, MMSc, to help nurses and nurse practitioners:
1) Understand the genetic consultation process
2) Examine genetic contribution to breast cancer
3) Identify suggestive family history patterns and risk estimation
4) Influence of genetic testing on management
Taken from a CNE-granting presentation given on 2/17/12 in Highland Park, IL, put together by the Chicago Center for Jewish Genetic Disorders and NorthShore University HealthSystem.
As more women are concerned with their hereditary breast & Gyneacological cancer risk, the threshold for genetic testing is falling .
Patients and family members should be supported & given information about chemoprevention, surveillance & risk-reducing surgery .
The true challenge lies in translation of this knowledge into clinical practice, such that a definitive improvement in longevity and quality of life for patients and their families is realized.
Surviving and Thriving with Gynecologic Cancer - 9.7.19Summit Health
Join Gynecologic Oncology and wellness experts for a special "brunch and learn," event for ovarian, cervical and other gynecologic cancer survivors and champions. Speaker-led sessions will cover innovation in treatment and complementary medicine to help manage menopause and other symptoms. Moderated by Darlene Gibbon, MD. FACOG, Medical Director of Gynecologic Oncology.
Other event materials can be found under the Patient Tools tab on this page: https://www.summitmedicalgroup.com/service/gynecological-oncology/
All in the Family: Hereditary Risk for Gynecologic Cancerbkling
Knowing and understanding your inherited genetics is important for ovarian and uterine cancer patients. Dr. Melissa Frey, gynecologic oncologist at Weill Cornell Medicine, discusses how genetic factors affect women with ovarian and uterine cancer and influence treatment decisions, with a particular focus on BRCA1 & 2 and Lynch Syndrome.
This webinar was being put on in partnership with FORCE.
SHARE, in partnership with Reproductive Medicine Associates of NY, FORCE, and Sharsheret, hold a presentation on fertility and family planning for patients recently diagnosed with cancer and those who are predisposed to hereditary cancer syndromes due to a genetic mutation. The presenter, Dr. Matthew Lederman, is a board-certified reproductive endocrinologist and infertility specialist.
Prophylaxis and early diagnosis of breast cancerINVICTA GENETICS
The BRCA 1/2 Test allows performing the analysis of the entire sequence coding both genes in order to detect the mutations which influence the increased risk of developing a cancer disease. One of the most important indications for performing the test is the positive family history.
Eric Fowler, MS, CGC, Certified/Licensed Genetic Counselor, manager of Genetic Counseling at Cancer Treatment Centers of America(r) presents "Know Your Risk: Understanding Genetics and Breast Cancer." The webinar presentation addresses genetics and genetic counseling basics, factors that impact breast cancer risk, family history risk, hereditary breast cancer and the pros and cons of genetic testing.
Brca2 mutation and their influence to cancergalinayakubova
brca2 mutation and their influence to cancer . and also the types of cancers caused by them. also mentions management and risk factors and classic pedigree of brca2 mutation. also mentions statistics of brca1 and brca2
All in the Family: Hereditary Risk for Gynecologic Cancerbkling
Knowing and understanding your inherited genetics is important for ovarian and uterine cancer patients. Dr. Melissa Frey, gynecologic oncologist at Weill Cornell Medicine, discusses how genetic factors affect women with ovarian and uterine cancer and influence treatment decisions, with a particular focus on BRCA1 & 2 and Lynch Syndrome.
This webinar was being put on in partnership with FORCE.
SHARE, in partnership with Reproductive Medicine Associates of NY, FORCE, and Sharsheret, hold a presentation on fertility and family planning for patients recently diagnosed with cancer and those who are predisposed to hereditary cancer syndromes due to a genetic mutation. The presenter, Dr. Matthew Lederman, is a board-certified reproductive endocrinologist and infertility specialist.
Prophylaxis and early diagnosis of breast cancerINVICTA GENETICS
The BRCA 1/2 Test allows performing the analysis of the entire sequence coding both genes in order to detect the mutations which influence the increased risk of developing a cancer disease. One of the most important indications for performing the test is the positive family history.
Eric Fowler, MS, CGC, Certified/Licensed Genetic Counselor, manager of Genetic Counseling at Cancer Treatment Centers of America(r) presents "Know Your Risk: Understanding Genetics and Breast Cancer." The webinar presentation addresses genetics and genetic counseling basics, factors that impact breast cancer risk, family history risk, hereditary breast cancer and the pros and cons of genetic testing.
Brca2 mutation and their influence to cancergalinayakubova
brca2 mutation and their influence to cancer . and also the types of cancers caused by them. also mentions management and risk factors and classic pedigree of brca2 mutation. also mentions statistics of brca1 and brca2
The Roman Empire A Historical Colossus.pdfkaushalkr1407
The Roman Empire, a vast and enduring power, stands as one of history's most remarkable civilizations, leaving an indelible imprint on the world. It emerged from the Roman Republic, transitioning into an imperial powerhouse under the leadership of Augustus Caesar in 27 BCE. This transformation marked the beginning of an era defined by unprecedented territorial expansion, architectural marvels, and profound cultural influence.
The empire's roots lie in the city of Rome, founded, according to legend, by Romulus in 753 BCE. Over centuries, Rome evolved from a small settlement to a formidable republic, characterized by a complex political system with elected officials and checks on power. However, internal strife, class conflicts, and military ambitions paved the way for the end of the Republic. Julius Caesar’s dictatorship and subsequent assassination in 44 BCE created a power vacuum, leading to a civil war. Octavian, later Augustus, emerged victorious, heralding the Roman Empire’s birth.
Under Augustus, the empire experienced the Pax Romana, a 200-year period of relative peace and stability. Augustus reformed the military, established efficient administrative systems, and initiated grand construction projects. The empire's borders expanded, encompassing territories from Britain to Egypt and from Spain to the Euphrates. Roman legions, renowned for their discipline and engineering prowess, secured and maintained these vast territories, building roads, fortifications, and cities that facilitated control and integration.
The Roman Empire’s society was hierarchical, with a rigid class system. At the top were the patricians, wealthy elites who held significant political power. Below them were the plebeians, free citizens with limited political influence, and the vast numbers of slaves who formed the backbone of the economy. The family unit was central, governed by the paterfamilias, the male head who held absolute authority.
Culturally, the Romans were eclectic, absorbing and adapting elements from the civilizations they encountered, particularly the Greeks. Roman art, literature, and philosophy reflected this synthesis, creating a rich cultural tapestry. Latin, the Roman language, became the lingua franca of the Western world, influencing numerous modern languages.
Roman architecture and engineering achievements were monumental. They perfected the arch, vault, and dome, constructing enduring structures like the Colosseum, Pantheon, and aqueducts. These engineering marvels not only showcased Roman ingenuity but also served practical purposes, from public entertainment to water supply.
The Art Pastor's Guide to Sabbath | Steve ThomasonSteve Thomason
What is the purpose of the Sabbath Law in the Torah. It is interesting to compare how the context of the law shifts from Exodus to Deuteronomy. Who gets to rest, and why?
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
How to Create Map Views in the Odoo 17 ERPCeline George
The map views are useful for providing a geographical representation of data. They allow users to visualize and analyze the data in a more intuitive manner.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxEduSkills OECD
Andreas Schleicher presents at the OECD webinar ‘Digital devices in schools: detrimental distraction or secret to success?’ on 27 May 2024. The presentation was based on findings from PISA 2022 results and the webinar helped launch the PISA in Focus ‘Managing screen time: How to protect and equip students against distraction’ https://www.oecd-ilibrary.org/education/managing-screen-time_7c225af4-en and the OECD Education Policy Perspective ‘Students, digital devices and success’ can be found here - https://oe.cd/il/5yV
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
The Indian economy is classified into different sectors to simplify the analysis and understanding of economic activities. For Class 10, it's essential to grasp the sectors of the Indian economy, understand their characteristics, and recognize their importance. This guide will provide detailed notes on the Sectors of the Indian Economy Class 10, using specific long-tail keywords to enhance comprehension.
For more information, visit-www.vavaclasses.com
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
BRCA ONCOLOGY.ppt
1. The Genetics Education Project
BRCA Genes
Prepared by : ibrahim issac
GENERAL and laparoscopic surgery
resident
2. The Genetics Education Project
Outline
Sporadic versus familial cancer
Hereditary breast cancer syndrome
What are BRCA GENES
Referral guidelines
Benefits, risks and limitations of genetic
testing
Management
3. The Genetics Education Project
Cancer
All cancer involves changes in genes….
Threshold effect:
During mitosis & DNA replication
– mutations occur in the cell’s genetic code
Mutations are normally corrected by DNA repair
mechanisms
If repair mechanism or cell cycle regulation damaged
– Cell accumulates too many mutations
→ reaches ‘threshold’
→ tumor development
4. The Genetics Education Project
Sporadic Cancer
All cancerS arises from changes in genes….
– But NOT all cancerS are inherited
Most breast cancer is sporadic ~ 80%
– Due to mutations acquired over a person’s
lifetime:
Cause unknown – multifactorial
– Interaction of many factors: age, environment,
lifestyle (obesity, alcohol), chance, unknown factors
– Sporadic cancer generally has a later onset
5. The Genetics Education Project
Clustering of Cancer in Families
11% lifetime risk of developing breast cancer
~20% of women with breast cancer have a family history:
10 -15% of breast cancer is familial:
– Due to some factor in the family
Environmental
Undiscovered gene mutation
Chance
Generally not eligible for genetic testing
5-10% of breast cancer is hereditary:
– Caused by an inherited gene mutation which causes increased risk for
cancer
Variety of cancer syndromes
About 2/3 of these - BRCA 1 or BRCA 2 mutations
May be eligible for genetic testing
6. The Genetics Education Project
Proportion of Hereditary Breast Cancer
Sporadic 80%
Familial 10-15%
Hereditary 5-10%
7. The Genetics Education Project
Knudson ‘two-hit’ Model
Sporadic Cancer
Birth: Two non-mutated
copies of the gene
One mutation in one gene;
Second gene non-mutated
ONE HIT
(hit=mutation)
SECOND
HIT
Two mutations - one in
each gene
CANCER
8. The Genetics Education Project
Knudson ‘two-hit’ Model
Inherited Cancer
Birth: Two 2 non-
mutated copies of the
BRCA1 gene
One mutation in one BRCA1
gene; One non-mutated copy
SECOND
HIT
Two mutations - one in
each BRCA1 gene
CANCER
Born with one hit
(hit = mutation)
9. The Genetics Education Project
Compared to sporadic cancer,
people with hereditary cancer have…
A higher risk of developing cancer
A younger age of onset of cancer
– Generally < 50 years of age
Multiple primary cancers
Hereditary cancer is less common in the
general population than sporadic cancer
10. The Genetics Education Project
Genes involved in hereditary
breast/ovarian cancer
> 2,600 mutations in:
–BRCA1- chromosome 17
[1994]
–BRCA2 - chromosome 13
(1995)
Autosomal dominant transmission
11. The Genetics Education Project
The gene names come from BReast CAncer
genes 1 & 2. The official names of these genes
is breast cancer1, early onset and breast
cancer2, early onset.
Everyone, male and female, has these genes
which normally work to repair DNA and are
involved in cell growth and cell division.
12. The Genetics Education Project
bb Bb
Bb bb Bb bb
Breast Cancer
Affected with
breast cancer
Autosomal Dominant Inheritance
Population
Risk
Population
Risk
Susceptible
BRCA gene
Unaffected
Legend
B: BRCA gene
with mutation
b: normal
BRCA gene
13. The Genetics Education Project
BRCA1 and BRCA2
What happens when their function is
compromised ?
Both genes are tumor suppressors:
–Regulation of cell growth
–Maintenance of cell cycle
Mutation leads to:
–Inability to regulate cell death
–Uncontrolled growth, cancer
14. The Genetics Education Project
Consequences of having a BRCA mutation
Estimated Risk in
BRCA Mutation
Carriers
– by Age 70
In General
Population
Breast Cancer ♀
BRCA1 & BRCA2
50 - 85% 11%
Ovarian Cancer
BRCA1
40-60% 1-2%
Ovarian Cancer
BRCA2
10-20% 1-2%
Breast Cancer ♂
BRCA2
6% <1%
15. The Genetics Education Project
Who should be offered referral for genetic
counselling and/or genetic testing?....
Multiple cases of breast and/or ovarian cancer in
family
– closely related relatives
– more than one generation
– Breast cancer diagnosed at < age 50
Breast cancer diagnosed at age < 35
Family member with both breast and ovarian cancers
Ashkenazi Jewish + relatives with breast or ovarian
cancer
16. The Genetics Education Project
…Who should be offered referral for
genetic counselling and/or genetic testing?
Family member with primary cancer in both breasts
Family member with invasive
serous ovarian cancer
Male breast cancer
Family member with an identified with
a BRCA1 or BRCA2 mutation
USPSTF 2005 recommends referral for genetic
counselling and evaluation for BRCA testing to women
with family history indicating increased risk of BRCA
mutations
18. The Genetics Education Project
Genetic Testing
Available at regional genetic centres
– Familial cancer clinics
Testing is only offered if the risk of
mutation is ≥10%
Test highest risk affected individual first
Only in exceptional circumstances will
testing be offered to unaffected
individuals
19. The Genetics Education Project
Results from Genetic Testing
Positive
– Deleterious mutation identified
Negative
– Interpretation differs if a mutation has previously been
identified in the family
Mutation known – true negative
Mutation unknown – uninformative
Variant of unknown significance
– Significance will depend on how variant tracks through
family - i.e. is variant present in people with disease?
– Can use software to predict functional significance
– Check with lab: ? reported previously
20. The Genetics Education Project
Risks/Benefits/Limitations
of genetic testing
Positive test result
Potential Benefits:
Clinical intervention may
improve outcome
Family members at risk can
be identified
Positive health behaviour
can be reinforced
Reduction of uncertainty
Potential Risks:
Adverse psychological reaction
Family issues/distress
Uncertainty -incomplete
penetrance
Confidentiality issues
Intervention carries risk
21. The Genetics Education Project
Risks/Benefits/Limitations
of genetic testing?
Negative test result
Potential Benefits:
Avoidance of unnecessary
clinical interventions
Emotional - relief
Children can be reassured
Avoidance of higher
insurance premiums
Potential Risks:
Adverse psychological
reaction (i.e. survivor guilt)
Dysfunctional family
dynamics
Complacent attitude to
health
22. The Genetics Education Project
Risks/Benefits/Limitations
of genetic testing?
Uninformative test result
Potential Benefits:
Future research may clarify
test results
Positive health behaviour
can be reinforced
Some relief
Higher insurance premiums
may be avoided
Potential Risks:
Continue clinical inventions
which may carry risks
Uncertainty
Continued anxiety
Higher insurance premiums
may not be reduced
23. The Genetics Education Project
What is the benefit of having genetic testing?
Can anything be done to change risk/outcome?
Recommendations for BRCA1 and BRCA2
mutation carriers:
– Lifestyle
Reduce dietary fat
Avoid obesity
Reduce alcohol consumption
Regular exercise
Weak
Evidence
24. The Genetics Education Project
What is the benefit of having genetic testing?
Can anything be done to change risk/outcome?
Recommendations for BRCA1/2 mutation carriers:
–Breast surveillance – “I” recommendation USPSTF 2005
Monthly BSE – unproven
CBE q6 months starting when carrier status identified
Annual mammography starting at age 30
MRI and U/S if surveillance required before age 30
MRI may have higher sensitivity for surveillance of breast
cancer among BRCA mutation carriers
– Studies ongoing
25. The Genetics Education Project
What is the benefit of having genetic testing?
Can anything be done to change risk/outcome?
Recommendations for BRCA1/2 mutation carriers:
– Ovarian surveillance
Consider…
– PV exam
– transvaginal ultrasound
– serum CA-125
» q6 months starting age 30-35
Symptom recognition
26. The Genetics Education Project
Management of Mutation Carriers –
Surgical options: Risk reduction mastectomy
Hartmann et al. NEJM 1999
– Retrospective study of 639 women with FH of breast cancer
who had bilateral mastectomy (mutation status unknown)
– Expected 37 br ca in 425 women at mod risk (Gail model)
– Observed 4 (90% risk reduction)
– 3 br ca in 214 high risk women with mastectomy (1.4%)
– 156 br ca in 403 sisters without mastectomy – 38.7% (90%
risk reduction)
Meijers-Heijboer et al. NEJM 2001
– 139 BRCA1 and BRCA2 mutation carriers
– No breast cancer after 3 years in 76 with risk-reducing
mastectomy compared with 8 cases of breast cancer in 63
who chose surveillance
27. The Genetics Education Project
Management of Mutation Carriers –
Surgical options: risk reduction salpingo-oophorectomy
(SO)
Kauff et al. NEJM 2002
– 170 women with BRCA1 or BRCA2 mutations
– Proportion free from br ca or ovarian ca at 5 years
94% (SO group) vs 69% p=0.006
– Hazard ratio for either cancer after SO: 0.25 (95% CI 0.08-0.74)
Rebbeck et al. NEJM 2002
– Breast cancer in 21% of SO group / 42% of control (hazard ratio
0.47)
– Hazard ratio for cancer of the coelomic epithelium after SO was
0.04
28. The Genetics Education Project
Management of Mutation Carriers –
Surgical options: risk reduction salpingo-
oophorectomy (SO)
Eisen et al. J Clin Oncol 2005
– Study of BRCA carriers who had SO and developed
breast cancer within 15 years
– Breast cancer in 51/1388 (3.5%) SO group / 115/1751
(6.2%) control group
– BRCA1: 56% reduction in breast cancer (OR 0.43, p =
0.00006)
– BRCA2: 46% reduction in breast cancer (OR 0.57, p =
0.11)
Summary: Consider for mutation carriers
before age 40
29. The Genetics Education Project
Management of Mutation Carriers -
Chemoprevention
Tamoxifen
– Invasive breast ca reduced from 42.5/1000 in placebo group to
24.8/1000 in Tamoxifen group in women at increased risk of
breast cancer
– Tamoxifen Prevention Trial 2005
– May show promise in estrogen +ve tumours associated with
BRCA2
Raloxifene
– Shows promise - conflicting data
Aromatase inhibitors – ExCel trial
– Exemestane vs. placebo (Ca Info Service – 1-888-939-3333)
31. The Genetics Education Project
Management of Mutation Carriers
Consider…
Additional psychosocial support for those with:
– History of depression/anxiety
– Poor coping skills
– Multiple losses in the family
– Loss of parent at a young age
– Recent loss
– Multiple surgical procedures
32. The Genetics Education Project
Important messages to share with
women
Most women will not develop breast cancer
– Of those who do – most will not have a known FH
For most women – increasing age is the greatest risk
factor
Great majority of women with FH of breast cancer do
not fall into a high-risk category and do not develop
breast cancer and are not eligible for genetic testing
Women at increased risk of breast cancer should be
“breast aware”